<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35563850</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2073-4409</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cells</Title>
          <ISOAbbreviation>Cells</ISOAbbreviation>
        </Journal>
        <ArticleTitle>An Early Disturbance in Serotonergic Neurotransmission Contributes to the Onset of Parkinsonian Phenotypes in <i>Drosophila melanogaster</i>.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">1544</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11091544</ELocationID>
        <Abstract>
          <AbstractText>Parkinson's disease (PD) is a neurodegenerative disease characterized by motor symptoms and dopaminergic cell loss. A pre-symptomatic phase characterized by non-motor symptoms precedes the onset of motor alterations. Two recent PET studies in human carriers of mutations associated with familial PD demonstrate an early serotonergic commitment-alteration in SERT binding-before any dopaminergic or motor dysfunction, that is, at putative PD pre-symptomatic stages. These findings support the hypothesis that early alterations in the serotonergic system could contribute to the progression of PD, an idea difficult to be tested in humans. Here, we study some components of the serotonergic system during the pre-symptomatic phase in a well-characterized <i>Drosophila</i> PD model, <i>Pink1<sup>B9</sup></i> mutant flies. We detected lower brain serotonin content in <i>Pink1<sup>B9</sup></i> flies, accompanied by reduced activity of SERT before the onset of motor dysfunctions. We also explored the consequences of a brief early manipulation of the serotonergic system in the development of motor symptoms later in aged animals. Feeding young <i>Pink1<sup>B9</sup></i> flies with fluoxetine, a SERT blocker, prevents the loss of dopaminergic neurons and ameliorates motor impairment observed in aged mutant flies. Surprisingly, the same pharmacological manipulation in young control flies results in aged animals exhibiting a PD-like phenotype. Our findings support that an early dysfunction in the serotonergic system precedes and contributes to the onset of the Parkinsonian phenotype in <i>Drosophila</i>.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zárate</LastName>
            <ForeName>Rafaella V</ForeName>
            <Initials>RV</Initials>
            <Identifier Source="ORCID">0000-0001-7250-9007</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago 8330025, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departamento Biomédico, Facultad de Ciencias de la Salud, Universidad de Antofagasta, Antofagasta 1240000, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hidalgo</LastName>
            <ForeName>Sergio</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-2604-156X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Entomology and Nematology, College of Agricultural and Environmental Sciences, University of California, Davis, CA 95616, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Navarro</LastName>
            <ForeName>Nicole</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-9793-6010</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago 8330025, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Molina-Mateo</LastName>
            <ForeName>Daniela</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago 8330025, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arancibia</LastName>
            <ForeName>Duxan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento Biomédico, Facultad de Ciencias de la Salud, Universidad de Antofagasta, Antofagasta 1240000, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rojo-Cortés</LastName>
            <ForeName>Francisca</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">0000-0003-2332-8423</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago 8330025, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oliva</LastName>
            <ForeName>Carlos</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago 8330025, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andrés</LastName>
            <ForeName>María Estela</ForeName>
            <Initials>ME</Initials>
            <Identifier Source="ORCID">0000-0002-2078-2770</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago 8330025, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zamorano</LastName>
            <ForeName>Pedro</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0001-7986-5880</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento Biomédico, Facultad de Ciencias de la Salud, Universidad de Antofagasta, Antofagasta 1240000, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto Antofagasta, Universidad de Antofagasta, Antofagasta 1240000, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Campusano</LastName>
            <ForeName>Jorge M</ForeName>
            <Initials>JM</Initials>
            <Identifier Source="ORCID">0000-0001-5254-8340</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago 8330025, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro Interdisciplinario de Neurociencia UC, Santiago 8331150, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cells</MedlineTA>
        <NlmUniqueID>101600052</NlmUniqueID>
        <ISSNLinking>2073-4409</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C493233">SerT protein, Drosophila</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D050486">Serotonin Plasma Membrane Transport Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.-</RegistryNumber>
          <NameOfSubstance UI="D011494">Protein Kinases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="C534484">PINK1 protein, Drosophila</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D029721" MajorTopicYN="Y">Drosophila Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011494" MajorTopicYN="N">Protein Kinases</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050486" MajorTopicYN="N">Serotonin Plasma Membrane Transport Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Drosophila melanogaster</Keyword>
        <Keyword MajorTopicYN="N">PINK1</Keyword>
        <Keyword MajorTopicYN="N">Parkinson’s disease</Keyword>
        <Keyword MajorTopicYN="N">SERT</Keyword>
        <Keyword MajorTopicYN="N">pre-symptomatic phase</Keyword>
        <Keyword MajorTopicYN="N">serotonin</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>1</Hour>
          <Minute>8</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35563850</ArticleId>
        <ArticleId IdType="pmc">PMC9105628</ArticleId>
        <ArticleId IdType="doi">10.3390/cells11091544</ArticleId>
        <ArticleId IdType="pii">cells11091544</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 1973;20:415–455. doi: 10.1016/0022-510X(73)90175-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0022-510X(73)90175-5</ArticleId>
            <ArticleId IdType="pubmed">4272516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kish S.J., Shannak K., Hornykiewicz O. Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson’s Disease. N. Engl. J. Med. 1988;318:876–880. doi: 10.1056/NEJM198804073181402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM198804073181402</ArticleId>
            <ArticleId IdType="pubmed">3352672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalia L.V., Lang A.E. Parkinson’s disease. Lancet. 2015;386:896–912. doi: 10.1016/S0140-6736(14)61393-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(14)61393-3</ArticleId>
            <ArticleId IdType="pubmed">25904081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Postuma R.B., Berg D. Prodromal Parkinson’s Disease: The Decade Past, the Decade to Come. Mov. Disord. 2019;34:665–675. doi: 10.1002/mds.27670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.27670</ArticleId>
            <ArticleId IdType="pubmed">30919499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buddhala C., Loftin S.K., Kuley B.M., Cairns N.J., Campbell M.C., Perlmutter J.S., Kotzbauer P.T. Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease. Ann. Clin. Transl. Neurol. 2015;2:949–959. doi: 10.1002/acn3.246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acn3.246</ArticleId>
            <ArticleId IdType="pmc">PMC4603378</ArticleId>
            <ArticleId IdType="pubmed">26478895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Politis M., Niccolini F. Serotonin in Parkinson’s disease. Behav. Brain Res. 2015;277:136–145. doi: 10.1016/j.bbr.2014.07.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbr.2014.07.037</ArticleId>
            <ArticleId IdType="pubmed">25086269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doder M., Rabiner E.A., Turjanski N., Lees A.J., Brooks D.J. Tremor in Parkinson’s disease and serotonergic dysfunction. Neurology. 2003;60:601–605. doi: 10.1212/01.WNL.0000031424.51127.2B.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/01.WNL.0000031424.51127.2B</ArticleId>
            <ArticleId IdType="pubmed">12601099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loane C., Wu K., Bain P., David J., Piccini P., Politis M. Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD. Neurology. 2013;80:1850–1855. doi: 10.1212/WNL.0b013e318292a31d.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0b013e318292a31d</ArticleId>
            <ArticleId IdType="pmc">PMC3908354</ArticleId>
            <ArticleId IdType="pubmed">23596065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kish S.J., Tong J., Hornykiewicz O., Rajput A., Chang L.J., Guttman M., Furukawa Y. Preferential loss of serotonin markers in caudate versus putamen in Parkinson’s disease. Brain. 2008;131:120–131. doi: 10.1093/brain/awm239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awm239</ArticleId>
            <ArticleId IdType="pubmed">17956909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasquini J., Ceravolo R., Qamhawi Z., Lee J.Y., Deuschl G., Brooks D.J., Bonuccelli U., Pavese N. Progression of tremor in early stages of Parkinson’s disease: A clinical and neuroimaging study. Brain. 2018;141:811–821. doi: 10.1093/brain/awx376.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awx376</ArticleId>
            <ArticleId IdType="pubmed">29365117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wile D.J., Agarwal P.A., Schulzer M., Mak E., Dinelle K., Shahinfard E., Vafai N., Hasegawa K., Zhang J., McKenzie J., et al.  Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: Cross-sectional studies. Lancet Neurol. 2017;16:351–359. doi: 10.1016/S1474-4422(17)30056-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(17)30056-X</ArticleId>
            <ArticleId IdType="pmc">PMC5477770</ArticleId>
            <ArticleId IdType="pubmed">28336296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson H., Dervenoulas G., Pagano G., Koros C., Yousaf T., Picillo M., Polychronis S., Simitsi A., Giordano B., Chappell Z., et al.  Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: A cross-sectional study. Lancet Neurol. 2019;18:748–759. doi: 10.1016/S1474-4422(19)30140-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(19)30140-1</ArticleId>
            <ArticleId IdType="pubmed">31229470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 1978;179:641–667. doi: 10.1002/cne.901790311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cne.901790311</ArticleId>
            <ArticleId IdType="pubmed">565370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Giovanni G., Di Matteo V., Pierucci M., Esposito E. Serotonin-dopamine interaction: Electrophysiological evidence. Prog. Brain Res. 2008;172:45–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18772027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Navailles S., De Deurwaerdère P. Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology. 2011;213:213–242. doi: 10.1007/s00213-010-2029-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00213-010-2029-y</ArticleId>
            <ArticleId IdType="pubmed">20953589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark I.E., Dodson M.W., Jiang C., Cao J.H., Huh J.R., Seol J.H., Yoo S.J., Hay B.A., Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 2006;441:1162–1166. doi: 10.1038/nature04779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature04779</ArticleId>
            <ArticleId IdType="pubmed">16672981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J., Lee S.B., Lee S., Kim Y., Song S., Kim S., Bae E., Kim J., Shong M., Kim J.M., et al.  Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 2006;441:1157–1161. doi: 10.1038/nature04788.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature04788</ArticleId>
            <ArticleId IdType="pubmed">16672980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuda N., Sato S., Shiba K., Okatsu K., Saisho K., Gautier C.A., Sou Y., Saiki S., Kawajiri S., Sato F., et al.  PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 2010;189:211. doi: 10.1083/jcb.200910140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200910140</ArticleId>
            <ArticleId IdType="pmc">PMC2856912</ArticleId>
            <ArticleId IdType="pubmed">20404107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vives-Bauza C., Zhou C., Huang Y., Cui M., de Vries R.L.A., Kim J., May J., Tocilescu M.A., Liu W., Ko H.S., et al.  PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl. Acad. Sci. USA. 2010;107:378–383. doi: 10.1073/pnas.0911187107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0911187107</ArticleId>
            <ArticleId IdType="pmc">PMC2806779</ArticleId>
            <ArticleId IdType="pubmed">19966284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molina-Mateo D., Fuenzalida-Uribe N., Hidalgo S., Molina-Fernández C., Abarca J., Zárate R.V., Escandón M., Figueroa R., Tevy M.F., Campusano J.M. Characterization of a presymptomatic stage in a Drosophila Parkinson’s disease model: Unveiling dopaminergic compensatory mechanisms. Biochim. Biophys. Acta-Mol. Basis Dis. 2017;1863:2882–2890. doi: 10.1016/j.bbadis.2017.07.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2017.07.013</ArticleId>
            <ArticleId IdType="pubmed">28716706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hidalgo S., Castro C., Zárate R.V., Valderrama B.P., Hodge J.J.L., Campusano J.M. The behavioral and neurochemical characterization of a Drosophila dysbindin mutant supports the contribution of serotonin to schizophrenia negative symptoms. Neurochem. Int. 2020;138:104753. doi: 10.1016/j.neuint.2020.104753.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuint.2020.104753</ArticleId>
            <ArticleId IdType="pubmed">32416114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hidalgo S., Molina-Mateo D., Escobedo P., Zárate R.V., Fritz E., Fierro A., Perez E.G., Iturriaga-Vasquez P., Reyes-Parada M., Varas R., et al.  Characterization of a Novel Drosophila SERT Mutant: Insights on the Contribution of the Serotonin Neural System to Behaviors. ACS Chem. Neurosci. 2017;8:2168–2179. doi: 10.1021/acschemneuro.7b00089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acschemneuro.7b00089</ArticleId>
            <ArticleId IdType="pubmed">28665105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Majeed Z.R., Ritter K., Robinson J., Blümich S.L.E., Brailoiu E., Cooper R.L. New insights into the acute actions from a high dosage of fluoxetine on neuronal and cardiac function: Drosophila, crayfish and rodent models. Comp. Biochem. Physiol. Part-C Toxicol. Pharmacol. 2015;176–177:52–61. doi: 10.1016/j.cbpc.2015.07.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cbpc.2015.07.010</ArticleId>
            <ArticleId IdType="pubmed">26232582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao X., Wang B., Zhang J., Yan T., Yang W., Jiao F., Liu J., Wang S. Localization of serotonin/tryptophan-hydroxylase-immunoreactive cells in the brain and suboesophageal ganglion of Drosophila melanogaster. Cell Tissue Res. 2010;340:51–59. doi: 10.1007/s00441-010-0932-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-010-0932-5</ArticleId>
            <ArticleId IdType="pubmed">20177707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colomb J., Reiter L., Blaszkiewicz J., Wessnitzer J., Brembs B. Open Source Tracking and Analysis of Adult Drosophila Locomotion in Buridan’s Paradigm with and without Visual Targets. PLoS ONE. 2012;7:e42247.  doi: 10.1371/annotation/41b2d3fd-e816-420c-80d0-88290796b1cd.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/annotation/41b2d3fd-e816-420c-80d0-88290796b1cd</ArticleId>
            <ArticleId IdType="pmc">PMC3415391</ArticleId>
            <ArticleId IdType="pubmed">22912692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alekseyenko O.V., Lee C., Kravitz E.A. Targeted Manipulation of Serotonergic Neurotransmission Affects the Escalation of Aggression in Adult Male Drosophila melanogaster. PLoS ONE. 2010;5:e10806.  doi: 10.1371/journal.pone.0010806.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0010806</ArticleId>
            <ArticleId IdType="pmc">PMC2875409</ArticleId>
            <ArticleId IdType="pubmed">20520823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whitworth A.J. Drosophila Models of Parkinson’s Disease. Adv. Genet. 2011;73:1–50. doi: 10.1016/B978-0-12-380860-8.00001-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/B978-0-12-380860-8.00001-X</ArticleId>
            <ArticleId IdType="pubmed">21310293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pooryasin A., Fiala A. Identified Serotonin-Releasing Neurons Induce Behavioral Quiescence and Suppress Mating in Drosophila. J. Neurosci. 2015;35:12792–12812. doi: 10.1523/JNEUROSCI.1638-15.2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1638-15.2015</ArticleId>
            <ArticleId IdType="pmc">PMC6795202</ArticleId>
            <ArticleId IdType="pubmed">26377467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pfaffl M.W. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res. 2001;29:e45.  doi: 10.1093/nar/29.9.e45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/29.9.e45</ArticleId>
            <ArticleId IdType="pmc">PMC55695</ArticleId>
            <ArticleId IdType="pubmed">11328886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guttman M., Boileau I., Warsh J., Saint-Cyr J.A., Ginovart N., McCluskey T., Houle S., Wilson A., Mundo E., Rusjan P., et al.  Brain serotonin transporter binding in non-depressed patients with Parkinson’s disease. Eur. J. Neurol. 2007;14:523–528. doi: 10.1111/j.1468-1331.2007.01727.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1468-1331.2007.01727.x</ArticleId>
            <ArticleId IdType="pubmed">17437611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu B.Y., Qiao J.X., Yong J. Meta-analysis of selective serotonin reuptake inhibitors (SSRIs) compared to tricyclic antidepressants (TCAs) in the efficacy and safety of anti-depression therapy in Parkinson’s disease(PD) patients. Iran. J. Pharm. Res. 2014;13:1213–1219. doi: 10.22037/ijpr.2014.1596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.22037/ijpr.2014.1596</ArticleId>
            <ArticleId IdType="pmc">PMC4232786</ArticleId>
            <ArticleId IdType="pubmed">25587309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandoval-Rincón M., Sáenz-Farret M., Miguel-Puga A., Micheli F., Arias-Carrión O. Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson’s disease. Front. Neurol. 2015;6:71. doi: 10.3389/fneur.2015.00071.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2015.00071</ArticleId>
            <ArticleId IdType="pmc">PMC4379942</ArticleId>
            <ArticleId IdType="pubmed">25873910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armstrong M.J., Okun M.S. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020;323:548–560. doi: 10.1001/jama.2019.22360.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2019.22360</ArticleId>
            <ArticleId IdType="pubmed">32044947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bu M., Farrer M.J., Khoshbouei H. Dynamic control of the dopamine transporter in neurotransmission and homeostasis. Npj Park. Dis. 2021;7:22. doi: 10.1038/s41531-021-00161-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41531-021-00161-2</ArticleId>
            <ArticleId IdType="pmc">PMC7935902</ArticleId>
            <ArticleId IdType="pubmed">33674612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boulet S., Mounayar S., Poupard A., Bertrand A., Jan C., Pessiglione M., Hirsch E.C., Feuerstein C., François C., Féger J., et al.  Behavioral Recovery in MPTP-Treated Monkeys: Neurochemical Mechanisms Studied by Intrastriatal Microdialysis. J. Neurosci. 2008;28:9575–9584. doi: 10.1523/JNEUROSCI.3465-08.2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.3465-08.2008</ArticleId>
            <ArticleId IdType="pmc">PMC6671121</ArticleId>
            <ArticleId IdType="pubmed">18799689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chung Y.C., Kim S.R., Park J.-Y., Chung E.S., Park K.W., Won S.Y., Bok E., Jin M., Park E.S., Yoon S.-H., et al.  Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology. 2011;60:963–974. doi: 10.1016/j.neuropharm.2011.01.043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuropharm.2011.01.043</ArticleId>
            <ArticleId IdType="pubmed">21288472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheunemann L., Plaçais P.Y., Dromard Y., Schwärzel M., Preat T. Dunce Phosphodiesterase Acts as a Checkpoint for Drosophila Long-Term Memory in a Pair of Serotonergic Neurons. Neuron. 2018;98:350–365.e5. doi: 10.1016/j.neuron.2018.03.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2018.03.032</ArticleId>
            <ArticleId IdType="pmc">PMC5919781</ArticleId>
            <ArticleId IdType="pubmed">29673482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fanibunda S.E., Deb S., Maniyadath B., Tiwari P., Ghai U., Gupta S., Figueiredo D., Weisstaub N., Gingrich J.A., Vaidya A.D.B., et al.  Serotonin regulates mitochondrial biogenesis and function in rodent cortical neurons via the 5-HT 2A receptor and SIRT1–PGC-1α axis. Proc. Natl. Acad. Sci. USA. 2019;116:11028–11037. doi: 10.1073/pnas.1821332116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1821332116</ArticleId>
            <ArticleId IdType="pmc">PMC6561197</ArticleId>
            <ArticleId IdType="pubmed">31072928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipton S.A., Kater S.B. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci. 1989;12:265–270. doi: 10.1016/0166-2236(89)90026-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0166-2236(89)90026-X</ArticleId>
            <ArticleId IdType="pubmed">2475939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carvajal-Oliveros A., Campusano J.M. Studying the Contribution of Serotonin to Neurodevelopmental Disorders. Can This Fly? Front. Behav. Neurosci. 2021;14:262. doi: 10.3389/fnbeh.2020.601449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnbeh.2020.601449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pratelli M., Migliarini S., Pelosi B., Napolitano F., Usiello A., Pasqualetti M. Perturbation of Serotonin Homeostasis during Adulthood Affects Serotonergic Neuronal Circuitry. Eneuro. 2017;4:ENEURO.0376-16.2017. doi: 10.1523/ENEURO.0376-16.2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/ENEURO.0376-16.2017</ArticleId>
            <ArticleId IdType="pmc">PMC5388670</ArticleId>
            <ArticleId IdType="pubmed">28413824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simpson K.L., Weaver K.J., De Villers-Sidani E., Lu J.Y.F., Cai Z., Pang Y., Rodriguez-Porcel F., Paul I.A., Merzenich M., Lin R.C.S. Perinatal antidepressant exposure alters cortical network function in rodents. Proc. Natl. Acad. Sci. USA. 2011;108:18465–18470. doi: 10.1073/pnas.1109353108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1109353108</ArticleId>
            <ArticleId IdType="pmc">PMC3215047</ArticleId>
            <ArticleId IdType="pubmed">22025710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sugie A., Marchetti G., Tavosanis G. Structural aspects of plasticity in the nervous system of I. Neural Dev. 2018;13:14. doi: 10.1186/s13064-018-0111-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13064-018-0111-z</ArticleId>
            <ArticleId IdType="pmc">PMC6026517</ArticleId>
            <ArticleId IdType="pubmed">29960596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Devaud J.-M., Acebes A., Ramaswami M., Ferrús A. Structural and functional changes in the olfactory pathway of adult Drosophila take place at a critical age. J. Neurobiol. 2003;56:13–23. doi: 10.1002/neu.10215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/neu.10215</ArticleId>
            <ArticleId IdType="pubmed">12767029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sachse S., Rueckert E., Keller A., Okada R., Tanaka N.K., Ito K., Vosshall L.B.B. Activity-Dependent Plasticity in an Olfactory Circuit. Neuron. 2007;56:838–850. doi: 10.1016/j.neuron.2007.10.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2007.10.035</ArticleId>
            <ArticleId IdType="pubmed">18054860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Golovin R.M., Vest J., Vita D.J., Broadie K. Activity-dependent remodeling of Drosophila olfactory sensory neuron brain innervation during an early-life critical period. J. Neurosci. 2019;39:2995–3012. doi: 10.1523/JNEUROSCI.2223-18.2019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2223-18.2019</ArticleId>
            <ArticleId IdType="pmc">PMC6468095</ArticleId>
            <ArticleId IdType="pubmed">30755492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poewe W., Seppi K., Tanner C.M., Halliday G.M., Brundin P., Volkmann J., Schrag A.E., Lang A.E. Parkinson disease. Nat. Rev. Dis. Prim. 2017;3:17013. doi: 10.1038/nrdp.2017.13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrdp.2017.13</ArticleId>
            <ArticleId IdType="pubmed">28332488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nielsen S.S., Warden M.N., Camacho-Soto A., Willis A.W., Wright B.A., Racette B.A. A predictive model to identify Parkinson disease from administrative claims data. Neurology. 2017;89:1448–1456. doi: 10.1212/WNL.0000000000004536.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000004536</ArticleId>
            <ArticleId IdType="pmc">PMC5631173</ArticleId>
            <ArticleId IdType="pubmed">28864676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heinzel S., Berg D., Gasser T., Chen H., Yao C., Postuma R.B. Update of the MDS research criteria for prodromal Parkinson’s disease. Mov. Disord. 2019;34:1464–1470. doi: 10.1002/mds.27802.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.27802</ArticleId>
            <ArticleId IdType="pubmed">31412427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faust I.M., Racette B.A., Nielsen S.S. Validation of a Parkinson Disease Predictive Model in a Population-Based Study. Parkinsons Dis. 2020;2020:2857608. doi: 10.1155/2020/2857608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2020/2857608</ArticleId>
            <ArticleId IdType="pmc">PMC7054801</ArticleId>
            <ArticleId IdType="pubmed">32148753</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
